CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,860 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01879072
NCT01879072N/ACompleted
CompareCT.gov

Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT (BMT CTN #1202)

Medical College of Wisconsin·observational·Posted Jun 17, 2013·Updated Dec 9, 2022

In Brief

An observational study for Allogeneic Hematopoietic Stem Cell Transplantation. Completed, enrolled 1,860 participants across 42 sites.

Detailed Summary

The goal of this protocol is to establish a cohort of at least 1500 biologic samples collected prospectively from patients treated in BMT CTN centers that will be a shared bio specimen resource for conducting future allogeneic hematopoietic stem cell transplantation (HCT) correlative studies.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAllogeneic Hematopoietic Stem Cell Transplantation
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI), Blood and Marrow Transplant Clinical Trials Network, National Marrow Donor Program

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 17, 2013
Enrollment StartJun 1, 2013
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 13.0 years ago